New registrations of interventional general practice randomised controlled trials in Australia remained relatively static between 2005 and 2024, according to a registry analysis published in BMC Primary Care.
The investigation was conducted by researchers Richard L. Reed and Leigh Roeger to document the frequency, longitudinal trajectories, and reporting outcomes of trial registrations.
To evaluate trial trends across the Australian primary healthcare sector, the research team examined records from the Australian and New Zealand Clinical Trials Registry, designated as ANZCTR. Their formal search protocol identified all interventional general practice clinical trials that were entered into the registry between the start date of 1 July 2005 and the concluding cutoff date of 30 June 2024.
The investigators established that the annual count of newly registered trials remained relatively static over time, recording an overall yearly mean of 8.8 trials accompanied by a standard deviation of 3.0 across the nineteen-year observation window.
In addition to quantifying trial registration rates, the researchers tracked how frequently completed trials disseminated their findings to the scientific community. Among the specific denominator of 115 trials that had concluded, 77.4 percent successfully reported their results in an academic journal publication, which accounted for a total of 89 completed trials with published outcomes.
The investigators also evaluated the specific outcome profiles documented among the completed studies that achieved publication in a medical journal. Within that cohort of 89 published trials, 39.3 percent reported positive findings, which corresponded to exactly 35 individual trials demonstrating positive interventional results within general practice settings.
Reflecting on the findings, the authors concluded that the overall volume of newly registered general practice trials has remained persistently static throughout the entire study period. They emphasized that substantial investment in research capability and research infrastructure will be required before any meaningful increases in Australian general practice clinical trial activity can be achieved.
Subject of Research: Trends and outcomes of Australian general practice randomised controlled trials
Article Title: Australian general practice randomised controlled trials: 2005–2024
Article References: Reed, R. L., & Roeger, L. (2026). Australian general practice randomised controlled trials: 2005–2024. BMC Primary Care. https://doi.org/10.1186/s12875-026-03565-2
Image Credits: AI Generated
DOI: 10.1186/s12875-026-03565-2
Keywords: Australian general practice, randomised controlled trials, clinical trial registry, ANZCTR, interventional trials, primary care research, trial registration trends, trial publication rates, journal reporting, positive trial outcomes, research infrastructure, research capability, evidence-based medicine, gold standard evidence, trial completion outcomes, longitudinal trial analysis, medical evidence generation
News Source: Ophelia Keating. (November 16, 2026). Australian General Practice Clinical Trial Registrations Remained Static Over Nineteen Years. Scienmag.



